FDA NDC Directory · JSON-LD · Markdown

Adbry

NDC 50222-350 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametralokinumab-ldrm
Labeler / ManufacturerLEO Pharma Inc.
Marketing categoryBiologic License Application · App BLA761180
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTRALOKINUMAB (300 mg/2mL)
Marketing started20240701
Package count3

External sources

Source: openFDA. Public-domain (CC0).